Bioorganic & Medicinal Chemistry

Papers
(The H4-Index of Bioorganic & Medicinal Chemistry is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Synthesis and antiproliferative activity of (−)-cleistenolide, (6S)-cleistenolide and 4-substituted cleistenolide analogues127
Current Japanese pharmaceutical chemistry115
Targeting prolidase. A survey of the literature data to depict a structure-activity relationship frame and to address future studies for drug development87
Innovative synthesis and purification method of fluorescent and bifunctional substrates for self-labelling protein tags71
Sulfadoxine derivatization through multicomponent reactions to obtain new antiplasmodial compounds71
Diterpenoids from the whole plants of Croton yunnanensis and their bioactivities44
Site-specific construction of triptolide-based antibody-drug conjugates42
Targeting m6A binding protein YTHDFs for cancer therapy42
Sustainable electrochemical C(sp3) − H oxygenation using water as the oxygen source41
Development of delivery carriers for plasmid DNA by conjugation of a helical template to oligoarginine40
Synthesis and medicinal chemistry of tetronamides: Promising agrochemicals and antitumoral compounds39
Graphical abstract TOC37
Synthesis and biological evaluation of pyrazole-fused oleanolic acid derivatives as novel inhibitors of inflammatory and osteoclast differentiation37
Graphical abstract TOC36
RNA-templated chemical synthesis of proapoptotic L- and d-peptides35
Design, synthesis and validation of a new Crimped Head-Piece for DNA-Encoded libraries generation34
Contents continued34
Production and synthesis of a novel 191Pt-labeled platinum complex and evaluation of its biodistribution in healthy mice33
Discovery of novel 2,8-diazaspiro[4.5]decan-1-one derivatives as potent RIPK1 kinase inhibitors32
Research progress of STAT3-based dual inhibitors for cancer therapy32
Design, synthesis and antibacterial evaluation of oxazolidinone derivatives containing N-methylglycyl or quaternary ammonium salts30
Crescent-shaped meta-substituted benzene derivatives as a new class of non-nucleoside ribonuclease A inhibitors30
Editorial Board30
A DNA-encoded library special issue30
Discovery of trisubstituted meta-carboranes as T cell activators by regulating CD28 cytoplasmic region and SH2 domains of Grb2 and PI3K interactions29
Design, synthesis and evaluation the bioactivities of novel 1,3-dimethyl-6-amino-1H-indazole derivatives as anticancer agents28
Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents28
Discovery of 3-hydroxymethyl-azetidine derivatives as potent polymerase theta inhibitors27
0.16419100761414